Aby J. Mathew (EVP & Chief Scientific Officer) sold ~$16K of BioLife Solutions, Inc.
Scheduled in advanceLoading…
Traded Nov 25, 2025 · Filed Nov 28, 2025
BioLife Solutions's Chief Technology Officer sold $2.9K of BioLife Solutions shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,941
Shares × reported transaction price
19 days after results of Nov 6, 2025, 48 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.8% | +0.5% | −2.3% |
| 30 days | −4.8% | +0.2% | −5.1% |
| 90 days | −11.4% | +0.9% | −12.3% |
| 180 days | +4.8% | +11.5% | −6.7% |
Past results only. Not a forecast.
Aby J. Mathew (EVP & Chief Scientific Officer) sold ~$16K of BioLife Solutions, Inc.
Scheduled in advanceTroy Wichterman (Chief Financial Officer) sold ~$26K of BioLife Solutions, Inc.
Scheduled in advanceSarah Aebersold (Chief Human Resources Officer) sold ~$5.9K of BioLife Solutions, Inc.
Scheduled in advance